Results 111 to 120 of about 61,873 (295)

A Survey of Selected Neurological Signs in Schizophrenia Research [PDF]

open access: yes, 2011
This review covers three areas of schizophrenia research not usually addressed in residents\u27 curricula: smooth pursuit eye movements and genetics, orienting responses, and tardive dyskinesia. The significance of these neurological signs is explored in
Rosen, M.D., Emanuel H.
core   +1 more source

Pharmacogenetics: a reality or misplaced optimism? [PDF]

open access: yes, 2012
The paper aims to review current evidence that supports the application of genetic information in the management and use of psychotropic medication. Although the importance of an individual's genetic makeup in the metabolism of drugs has been known for ...
Arranz   +43 more
core   +1 more source

Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia

open access: yesInternational Journal of Neuropsychopharmacology, 2015
Background: Tardive dyskinesia is a disorder characterized by involuntary muscle movements that occur as a complication of long-term treatment with antipsychotic drugs.
O. Fedorenko   +9 more
semanticscholar   +1 more source

Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review [PDF]

open access: yes, 2014
Schizophrenia is a chronic condition that impacts significantly not only on the individual and family, but the disorder also has wider consequences for society in terms of significant costs to the economy.
James Neil   +2 more
core   +1 more source

Medical treatment of dystonia [PDF]

open access: yes, 2016
Therapeutic strategies in dystonia have evolved considerably in the past few decades. Three major treatment modalities include oral medications, botulinum toxin injections and surgical therapies, particularly deep brain stimulation.
Pichet Termsarasab   +2 more
core   +2 more sources

Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases

open access: yesInternational journal of clinical practice, 2014
To assess the tardive dyskinesia (TD) rate in studies of once‐monthly long‐acting injectable (LAI) paliperidone palmitate (PP) and once‐daily oral paliperidone extended release (Pali ER).
S. Gopal   +7 more
semanticscholar   +1 more source

Antipsychotic drugs: is more worse? a meta-analysis of the published randomized control trials [PDF]

open access: yes, 2017
Effectiveness and side-effects of high- versus low-dose neuroleptic treatment of chronic psychosis have been assessed through a meta-analysis of 22 published randomized control trials comparing different neuroleptic doses.
Adams, M. E.   +4 more
core  

Assessment of neuroleptic-induced movement disorders in a naturalistic schizophrenia population [PDF]

open access: yes, 2006
The prevalence and assessment of neuroleptic-induced movement disorders (NIMDs) in a naturalistic schizophrenia population that uses conventional neuroleptics were studied.
Janno, Sven
core  

Olanzapine-induced tardive oculogyric crises

open access: yesIndian Journal of Psychological Medicine, 2013
Tardive syndromes are much lower in prevalence in second generation antipsychotics (SGA) than in the typical antipsychotics. Although, olanzapine, which is an SGA, has a high risk of causing weight gain, metabolic syndrome, raised blood sugar, and ...
Amar D Bavle, Girish M. N. Kumar
doaj   +1 more source

Clonidine in the Treatment of Tardive Dyskinesia: A Case Review [PDF]

open access: yes, 2011
Over the past several years, a number of cardiovascular preparations have become widely used in psychiatry. For example, propranolol, introduced for its anti-anginal properties, is now used for stage-fright, lithium tremor and neuroleptic induced ...
Goodwin, MD, MPH, Jean   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy